
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tobacco Leaf Extract
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Recipient : NFL Biosciences
Deal Size : Undisclosed
Deal Type : Partnership
NFL Biosciences Partners with Themis Medicare for the Development of NFL-101 in India
Details : Under the partnership to develop NFL-101, the company’s drug candidate Tobacco leaf protein for smoking cessation, for the Indian market with Themis Medicare Ltd., will purchase Active Pharmaceutical Ingredient (API) from NFL Biosciences.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Undisclosed
October 05, 2022
Lead Product(s) : Tobacco Leaf Extract
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Recipient : NFL Biosciences
Deal Size : Undisclosed
Deal Type : Partnership
